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Abstract 
Objective: To explore personality and readiness to change among substance use disorders (SUD) patients with and 
without ADHD. Method: SUD + ADHD versus SUD  ADHD patients consecutively entering treatment between 2010 
and 2012 were compared concerning personality (Temperament and Character Inventory) and readiness to change 
(Stages of Change Readiness and Treatment Eagerness Scale). Results: Among 103 SUD patients (76 men, age M = 43.3, 
SD = 11.1), 16 (15.5%) were diagnosed with ADHD. SUD + ADHD patients reported significantly elevated eagerness to 
effort (p = .008) compared with SUD  ADHD patients, who reported significantly elevated fear of uncertainty (p < 
.000). SUD + ADHD patients reported higher ambition (p = .025), self-forgetfulness (p = .029), and lower recognition (p 
= .022). They were younger (p = .019) and showed more often amphetamine addiction (p = .022) compared with SUD  
ADHD patients. Conclusion: The distinct characteristics found in SUD + ADHD and SUD  ADHD patients underline 
the need for differentiated treatment interventions. (J. of Att. Dis. XXXX; XX(X) XX-XX) 
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ADHD is a neurodevelopmental disorder (American 
Psychiatric Association [APA], 2013), prevalent in around 
5% of the adult population (Willcutt, 2012). The core 
symptoms of ADHD, inattention, impulsivity and 
hyperactivity (Biederman et al., 2012) often manifest in 
adults as forgetting important appointments, having 
difficulties in planning and organizing everyday life tasks 
(Miranda, Berenguer, Colomer, & Rosello, 2014). Adults 
with ADHD may also seek immediate rewards without 
considering the consequences of their behavior (Sonuga-
Barke, 2003). Other challenges such as over-talkativeness, 
inner restlessness (Kooij et al., 2010) or emotional 
dysregulation (Asherson, Buitelaar, Faraone, & Rohde, 
2016) are often present in adults with ADHD. 
Substance use disorders (SUD) are characterized by a 
compulsive substance use, tolerance, withdrawal, and 
craving of addictive substances in spite of negative 
consequences and by unsuccessfully trying to stop using 
(APA, 2000, 2013). 
ADHD is frequently comorbid with SUD (Wilens et al., 
2005). Among SUD treatment seekers prevalence rates 
between 5% and 31% of ADHD have been reported (van 
de Glind et al., 2014). 
In clinical settings, SUD + ADHD adults are found to 
be younger (Johann, Bobbe, Putzhammer, & Wodarz, 
2003) and to have substantially higher rates of other 
psychiatric comorbidity (van Emmerik-van Oortmerssen et 
al., 2014) compared with SUD  ADHD adults. SUD + 
ADHD adults exhibit more severe and earlier onset of 
substance use, which develops faster into addiction 
(Ohlmeier et al., 2007) and have been found to have higher 
rates of SUD treatment drop out than SUD  ADHD adults 
(Levin et al., 2004). 
Both SUD and ADHD are impairing brain disorders 
(APA, 2013; Volkow & Baler, 2014) with similar 
cognitive, emotional, reward, and motivational deficits 
(Asherson et al., 2016; Volkow & Baler, 2014). Moreover, 
individuals with SUD + ADHD often experience a lack of 
control over own lives (Løvaas & Dahl, 2013). 
Personality 
Cloninger, Przybeck, Svrakic, and Wetzel (1994) describe 
personality in light of temperament (mainly biologically 
determined and stable over time) and character 
(susceptible to environmental influences). Four traits 
comprise temperament: novelty seeking, harm avoidance, 
reward dependence, and persistence. Three domains 
comprise character: self-directedness, cooperativeness, and 
self-transcendence (for a detailed description, see 
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Cloninger et al., 1994). There is limited literature 
comparing specifically SUD patients with and without 
ADHD. However, high novelty seeking (Sizoo, van den 
Brink, Gorissen van Eenige, & van der Gaag, 2009) and 
low cooperativeness (Hofvander et al., 2011) are found to 
characterize adults with comorbid SUD and ADHD. 
Otherwise, the literature suggests that adults with ADHD 
show elevated novelty seeking and harm avoidance 
(Evren, Evren, Yancar, & Erkiran, 2007; Le Bon et al., 
2004), self-transcendence (Faraone, Kunwar, Adamson, & 
Biederman, 2009), and lowered self-directedness and 
cooperativeness (Salgado et al., 2009). 
Readiness to Change 
The stages of change model is a framework to understand 
how people intentionally change problematic behavior and 
is widely used in SUD treatment (Nidecker, DiClemente, 
Bennett, & Bellack, 2008; Prochaska, DiClemente, & 
Norcross, 1992). The six stages of change are 
precontemplation (no recognition of the problematic 
behavior), contemplation (ambivalence), preparation 
(readiness), action (taking steps to change), maintenance, 
and relapse (Prochaska et al., 1992). Research on adults 
with SUD alone or with additional mental diseases 
suggests that executive functioning, awareness of 
symptom severity and self-reflection are important 
enablers of readiness to change problematic substance use 
(Blume & Schmaling, 1997; Blume, Schmaling, & 
Marlatt, 2005; Le Berre et al., 2012). The issues related to 
attentional problems, reward-processing, and inhibitory 
deficits may challenge the process of change, particularly 
in SUD + ADHD patients due to their inattention problems 
(Marx, Krause, Berger, & Hassler, 2014). 
Based on some evidence that SUD patients with and 
without ADHD differ in personality styles and readiness to 
change, the question arises whether treatment interventions 
should adapt to the needs of the different groups. Although 
the concepts personality and readiness to change are 
widely used in the SUD field (Belcher, Volkow, Moeller, 
& Ferre, 2014; DiClemente, Schlundt, & Gemmell, 2004; 
Nidecker et al., 2008), research on their utility is still 
limited. The present naturalistic study aimed to explore 
possible differences in personality and readiness to change 
between SUD + ADHD and SUD  ADHD patients 
referred to SUD treatment. Our research questions were 
the following: 
1. Do SUD + ADHD patients show higher novelty 
seeking, higher self-transcendence, and lower harm 
avoidance compared with SUD  ADHD patients? 
2. Do both patient groups show low self-directedness 
and cooperativeness? 
3. Do SUD + ADHD patients show lower readiness to 
change than SUD  ADHD patients? 
Method 
Participants 
The recruitment process is shown in Figure 1. Altogether, 
216 previously detoxicated patients consecutively entering 
SUD treatment between February 2010 and July 2012 at 
the University hospital in Northern Norway were eligible: 
193 from the ReStart Unit and 23 from the Therapeutic 
Community Færingen Unit. Exclusion criteria were 
behavior hindering compliance (e.g., aggressiveness), 
serious mental conditions (e.g., psychosis, dementia), 
physical conditions (e.g., chronic pain), or not speaking 
the Norwegian language. Those who accepted to 
participate signed informed consent after having received 
written and oral information about the study. 
Writing/reading assistance was offered. Due to ethical 
considerations, it was not possible to make inferences 
between SUD patients agreeing to participate and those 
declining. 
ADHD diagnosis. From a sample of 103 SUD patients, 24 
were assessed for ADHD by clinical experts, 
independently of this naturalistic study. We obtained 
information on the assessment and diagnosis of ADHD 
(International Classification of Diseases 10th Revision 
ICD-10; World Health Organization, 1992) from chart 
reviews.[AQ2] The ADHD assessment was well 
documented in the medical records and followed the 
national guidelines for the diagnosis of ADHD (Sosial-og 
Helsedirektoratet, 2007).[AQ3] Eight patients were 
assessed for ADHD at the time of the study and 16 before 
the study. From SUD + ADHD patients only, information 
regarding age at assessment and previous and present 
pharmacological treatment for ADHD was collected. 
Pharmacological treatment was routinely monitored by the 
units’ physicians. 
Measures 
In both wards, current Axis I psychopathology was 
assessed by means of the psychiatric interview M.I.N.I. 
PLUS (Sheehan et al., 1994). In the unit ReStart, the 
majority of interviews were conducted by trained 
clinicians and reviewed by the unit’s chief psychologist, 
who made the final evaluation. Axis II disorders were 
assessed in both wards only when considered necessary 
and then conducted by the chief psychologist utilizing 
Structured Clinical Interview for DSM-IV (SCID II; First, 
Spitzer, Gibbon, Williams, & Benjamin, 1995). ICD-10 
diagnostic criteria were applied. 
Personality was measured with the Temperament and 
Character Inventory (TCI; Cloninger et al., 1994). TCI 
consists of 240 items with dichotomous response 
alternatives (true/false). Although there is limited 
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Figure 1. Study flowchart for SUD patients with and without ADHD. 
Note. SUD = substance use disorders. 
 
 
TCI version, reliability coefficients from other versions 
have been satisfactory (Cloninger et al., 1994). The 
internal consistency of the four temperament dimensions 
were .74, .88, .77, and .88 and for the three character 
dimensions .87, .85, and .78, respectively. 
Readiness to change was measured by the Stages of 
Change Readiness and Treatment Eagerness, client version 
(SOCRATES 8), based on the readiness to change model 
previously described (Miller & Tonigan, 1996). The 
SOCRATES consists of three subscales comprising 19 
items on a 5-point Likert-type scale (ranging from 1 = 
strongly disagree to 5 = strongly agree). The three 
SOCRATES subscales are recognition (scores > 32 = 
medium or higher indicate increased recognition of having 
a problematic substance use), ambivalence (scores > 15 = 
medium or higher indicate increased ambivalence in 
relation to the substance of use) and taking steps (scores > 
33 = medium or higher, indicate high degree of taking 
action to change problematic substance use; Miller & 
Tonigan, 1996). The SOCRATES has been found to be 
useful for the assessment of readiness to change in alcohol 
and other substances (Burrow-Sanchez & Lundberg, 
2007). Participants completed one questionnaire for each 
substance they considered themselves having problems 
with. Cronbach’s alpha coefficients for recognition (.85-
.94), for ambivalence (.37-.88), and for taking steps (.82-
.95) were in line with previous studies (Abiola, Udofia, 
Sheikh, & Sanni, 2015; Miller & Tonigan, 1996). 
Self-reported alcohol consumption was measured by the 
Alcohol Use Disorder Identification Test (AUDIT; Babor, 
Higgins-Biddle, Saunders, & Monteiro, 2001). AUDIT 
consists of 10 questions on the frequency of alcohol use, 
providing five response options (never = 0, daily = 4) 
except for the last two questions (never = 0, not this last 
year = 2, during the last year = 4) and yielding a maximum 
score of 40. Scores >8 indicate risk drinking, whereas 
excessive drinking is present if scores are >20 (Babor et 
al., 2001). Internal consistency reliability of Cronbach’s 
alpha .77 has been reported previously (Rumpf, Wohlert, 
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Freyer-Adam, Grothues, & Bischof, 2013), compared  
with .93 in this study. 
Self-reported drug use was assessed by means of the 
Drug Use Disorder Identification Test (DUDIT; Berman, 
Bergman, Palmstierna, & Schlyter, 2005). DUDIT is 
similar to AUDIT in structure, consisting of 11 questions, 
yielding a maximum score of 44. Scores >25 are 
associated with substance dependence (Berman et al., 
2005). Cronbach’s alpha coefficients reported have been 
between .80 and .90 (Hildebrand, 2015), compared with 
.98 in the present study. 
ADHD symptoms were measured with the 18-item 
version of the Adult ADHD Self-Report Scale (ASRS; 
Kessler et al., 2005), which is based on the Diagnostic and 
Statistical Manual of Mental Disorders (4th ed., text rev.; 
DSM-IV-TR; APA, 2000) ADHD diagnostic criteria (APA, 
2000). The answer alternatives are provided by a 5-point 
Likert-type format (never = 0, very often = 4). The first six 
items comprising part A also constitute the ASRS screener 
(i.e., ASRS v.1.1), which has been found to be more 
predictive of ADHD (Kessler et al., 2005). We preferred 
the full version over the screener version of the ASRS to 
be able to compare both SUD groups in all 
symptomatology. Maximum scores for part A is 24 and 48 
for part B. Scores of 14 and above on the ASRS represent 
a high ADHD symptomatology (Kessler et al., 2005). 
Cronbach’s alpha coefficients have been previously 
reported to be .86 for both subscales (Gjervan, Torgersen, 
Rasmussen, & Nordahl, 2014), compared with .88 for part 
A and .93 for part B in our study. 
Statistical Analyses 
Initially, we calculated mean, standard deviation, 
median and range for all scales, and continuous 
variables and percentages for the categorical variables. 
These calculations were performed on all SUD patients 
as well as split data by ADHD diagnosis or not. To test 
for differences between the SUD + ADHD group and 
SUD  ADHD group in the primary analyses, we used 
chi-square tests for categorical variables and both t-tests 
and Mann–Whitney U-tests for scale and continuous 
variables. Since all Mann–Whitney p values were 
similar to those from the t-tests, we present only t-tests 
results. Regarding TCI, we report intergroup differences 
on temperament and character traits and subdimensions. 
Regarding the SOCRATES subscales, participants 
completed a questionnaire for each substance they 
considered having problems with. Due to these repeated 
measurements in the SOCRATES, we used a mixed 
model with individual as random factor, generic group 
as well as the ADHD diagnosis as fixed factors. To test 
for consistency of findings, we expanded the statistical 
models to either a multiple linear regression or logistic 
regression model adjusting for possible confounders 
such as age and comorbid mood disorders. We 
additionally adjusted for substance use/psychiatric 
problems and ADHD in consanguineous relatives as 
self-reported by all SUD patients. Effect size (Cohen’s 
d) was calculated. Due to multiple testing, we have 
lowered our significance level to < .01, whereas results 
with p value < .05 were regarded as tendencies. SPSS 
v.22 (IBM Corp, 2013) and the statistical computing 
language R (R Core Team, 2015) were used for the 
statistical analyses. For the mixed model regarding the 
SOCRATES, we used R-function lmer() in package 
lme4 (Bates, Maechler, Bolker, & Walker, 2015). 
Ethics 
The study was approved by the regional committees for 




The study comprised 76 male and 27 female SUD 
patients with a mean age of 43.1 and 44.0 years, 
respectively (data not shown). As there were only two 
women among the 16 participants diagnosed with 
ADHD, it was not possible to adjust for gender when 
comparing the SUD + ADHD group with the SUD  
ADHD group. As shown in Table 1, no significant 
differences between groups were found. However, SUD 
+ ADHD patients tended (p < .05) to be younger, were 
less often diagnosed with alcohol use disorders and 
more often with amphetamine use disorders compared 
with the SUD  ADHD patients. 
ADHD diagnosis. Of the 24 participants assessed for ADHD 
(four women), 21 (91.4%) underwent ADHD assessment 
as adults (three women). Eight out of the 24 assessed did 
not fulfill ADHD criteria. Mean age at time of ADHD 
diagnosis for the remaining 16 SUD patients (15.5%) was 
33.7 10.5 years, range = 28-50. Mean observation time 
(e.g., since ADHD diagnosis was received and the current 
study) was 3.7 3.5 years, range = 22-50. At the time of 
the study, seven SUD + ADHD patients were treated 
psychopharmacologically with either short or long-acting 
methylphenidate for their ADHD, whereof five reported 
positive to very positive response. 
Table 2 presents the comparison between SUD + 
ADHD versus SUD  ADHD patients in terms of 
personality and readiness to change. We report age-
adjusted results only because similar results were found 
after adjusting for either age alone, age and comorbid 
mood disorders or age and substance use 
problems/psychiatric problems/ADHD diagnosis in first-
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degree and second-degree family members (self-reported 
hereditary aspects are found in Table 3). 
 
Table 1. Sociodemographic and Clinical Characteristics of SUD Patients by ADHD Diagnosis (N = 103). 
Patient characteristics 
All SUD patients 
SUD + ADHD 
group 
SUD  ADHD 
group 
SUD + ADHD vs.  
SUD  ADHD 
M SD % n M SD % n M SD % n Statistic p  
Age 43.3 11.1  103 37.4 8.5  16 44.4 11.2  87 t = 2.38 .019 * 
Onset age of substance use 15.1 5.0  96 13.6 2.7  15 15.4 5.2  81 t = 1.32 .191  
Gender: Men   73.8 76   87.5 14   71.3 62 2 = 1.10 .295  
Living with partner: Yes (missing = 1)   19.6 20   18.8 3   19.8 17 2 = 0.19 .907  
Education             2 = 0.18 .916  
 Compulsory educationa   40.8 42   43.8 7   40.2 35    
 Senior secondary educationb   50.5 52   50.0 8   50.6 44    
 Higher education   8.7 9   6.2 1   9.2 8    
Incomec (missing = 1)             2 = 2.27 .519  
 Paid work   8.8 9   6.2 1   9.3 8    
 Temporary social welfared   52.0 53   68.8 11   48.8 42    
 Permanent disability welfaree   32.4 33   18.8 3   34.9 30    
 Under education   6.9 7   6.2 1   7 6    
Occupational status (missing = 3) 
 Employedf   17.0 17   6.7 1   18.8 16    
 Unemployed   82.0 82   86.7 13   81.2 69    
 Under education   1.0 1   6.7 1   0 0    
Housing conditionsc             2 = 0.64 .725  
 Homeless/shelter/living with others   19.4 20   25.0 4   18.4 16    
 Owned or rented residenceg   70.9 73   62.5 10   72.4 63    
 Institution   9.7 10   12.5 2   9.2 8    
Suicidal attempt: Yes (missing = 2)   40.6 41   18.8 3   44.7 38 2 = 2.76 .096  
Previous treatment for mental health problems: Yesh  
(missing = 1) 
  77.5 79   87.5 14   75.6 65 2 = 0.52 .500  
Previous SUD treatment: Yesh (missing = 2)   73.3 74   81.2 13   71.8 61 2 = 0.23 .632  
Axis I current disorders (F20-F50)   21.4 22   18.8 3   21.8 19 2 = 0.00 1.000  
Axis II personality disorders (F60)   3.9 4   0 0   4.6 4    
SUD diagnoses (F10-F15) 
 Alcohol   67.0 69   37.5 6   72.4 63 2 = 5.95 .015 * 
 Opioidsi   19.4 20   25.0 4   18.4 16 2 = 0.07 .787  
 Cannabis   21.4 22   18.8 3   21.8 19 2 = 0.00 1.000  
 Benzodiazepines   14.6 15   18.8 3   13.8 12 2 = 0.02 .896  
 Amphetamines   29.1 30   56.2 9   24.1 21 2 = 5.29 .022 * 
 Two or more SUD diagnoses   35.9 37   43.8 7   34.5 30 2 = 0.18 .670  
 Only SUD diagnoses   75.7 78   81.2 13   74.7 65 2 = 0.06 .808  
Self-reported substance usej 
 Alcohol   66.0 68   50.0 8   67.0 60 2 = 1.40 .236  
 Opioids   12.6 13   12.5 2   12.6 11 2 = 0.00 1.000  
 Cannabis   27.2 28   37.5 6   25.3 22 2 = 0.49 .482  
 Benzodiazepines   11.7 12   18.8 3   10.3 9 2 = 0.29 .590  
 Amphetamines   28.2 29   50.0 8   24.1 21 2 = 3.28 .070  
Note. SUD = substance use disorders; t = student t-statistic; 2 = Pearson’s chi-square statistic. 
aTen years of compulsory education included three unfinished education. 
bIncluding both academic oriented and vocationally oriented (3 and 4 years, respectively). 
cFour weeks prior to SUD treatment. 
dIncluding sick leave, unemployment, and rehabilitation. 
eIncluding disability pension and retirement. 
fIncluding part-time. 
gIncluding municipal residence. 
hIncluding polyclinical and/or institution. 
iReceiving opioid replacement therapy: 31.4% (n = 13). 
jPatients reported the substances they considered having problems with, which in many cases was more than one. Therefore, the counts in self-
reported substance use differ from N participants. 
*p  .05 (two-tailed). 
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Table 2. Comparison of the Degree of Substance Use, ADHD Symptoms, Personality and Readiness to Change in SUD + ADHD and 
SUD  ADHD Patients (N = 97). 
Variables 
All SUD patients SUD + ADHD group SUD  ADHD group SUD + ADHD vs. SUD  ADHD 
M SD N M SD N M SD N 95% CI t  p  Cohen’s d Adjusteda p  
AUDIT 21.4 11.7 97 14.0 11.7 16 22.9 11.2 81 15.0, 2.8] 2.89 .005 ** 0.79 .017 * 
DUDIT 15.6 17.1 97 24.1 16.3 16 13.9 16.8 81 [1.0, 19.2] 2.21 .029 * 0.61 .363  
ASRS   97              
 Part A 12.5 5.9  17.4 4.6 16 11.5 5.7 81 [2.9, 8.9] 3.90 .000 *** 1.07 .003 ** 
 Part B 24.2 10.0  32.1 7.3 16 22.6 9.8 81 [4.3, 14.6] 3.67 .000 *** 1.00 .005 ** 
SOCRATES   150b   27b   123b        
 Recognition 29.5 6.1  26.4 6.0  30.2 5.9  6.2, 0.8] 2.57 .010 ** 0.67c .022 * 
 Ambivalence 13.1 4.1  12.3 3.8  13.2 4.1  2.8, 1.4] 0.67 .506  0.27c .581  
 Taking steps 34.9 5.5  36.3 3.7  34.6 5.8  1.1, 4.4] 1.15 .249  0.39c .340  
TCI-Temperament 
 Novelty-seeking 19.9 5.2 92 23.1 4.7 15 19.3 5.1 77 [0.9, 6.5] 2.63 .010 ** 0.74 .108  
  Impulsiveness 4.9 2.1 92 6.0 1.9 15 4.7 2.1 77 [0.2, 2.5] 2.25 .027 * 0.64 .159  
 Harm avoidance 18.8 7.0 92 14.9 6.1 15 19.6 7.0 77 8.5, 0.8] 2.40 .019 * 0.68 .018 * 
  Fear of uncertainty 4.4 1.8 92 2.8 1.5 15 4.7 1.7 77 2.8, 1.0] 4.07 .000 *** 1.15 .000 *** 
  Fatigability 4.6 2.4 92 3.5 2.6 15 4.8 2.3 77 2.6, 0.0] 2.00 .049 * 0.56 .064  
 Reward dependence 17.2 4.9 92 16.5 4.4 15 17.4 5.0 77 3.7, 1.8] 0.67 .504  0.19 .633  
  Dependence 3.8 1.2 92 3.1 1.0 15 3.9 1.2 77 1.4, 0.1] 2.24 .028 * 0.63 .053 * 
 Persistence 17.1 7.4 92 21.1 8.1 15 16.3 7.1 77 [0.7, 8.9] 2.34 .021 * 0.66 .017 * 
  Eagerness to effort 4.2 2.8 92 5.6 2.6 15 3.9 2.7 77 [0.2, 3.2] 2.19 .031 * 0.62 .008 ** 
  Ambitious 4.1 2.2 92 5.6 2.4 15 3.8 2.1 77 [0.5, 3.0] 2.89 .005 ** 0.82 .025 * 
TCI-Character 
 Self-directedness 22.3 7.7 92 22.5 7.6 15 22.2 7.7 77 4.1, 4.6] 0.11 .915  0.03 .641  
 Cooperativeness 25.5 6.1 92 25.3 4.7 15 25.6 6.3 77 3.7, 3.2] 0.14 .891  0.04 .769  
 Self-transcendence 9.6 4.7 92 11.7 4.3 15 9.2 4.7 77 0.1, 5.1] 1.92 .057  0.54 .077  
  Self-forgetful 4.6 2.4 92 6.1 1.7 15 4.4 2.4 77 [0.5, 3.1] 2.76 .007 ** 0.78 .029 * 
Note. SUD = substance use disorders; CI = confidence interval = AUDIT = Alcohol Use Disorder Identification Test; DUDIT = Drug Use Disorder 
Identification Test; ASRS = Adult ADHD Self-Report Scale; SOCRATES = The Stages of Change Readiness and Treatment Eagerness Scale; TCI = 
Temperament and Character Inventory. 
aAdjusted for age. 
bPatients completed one questionnaire for each substance they considered as problematic. For this variable, n represents the number of completed 
questionnaires, rather number of patients. 
cAdjusted for generic group in a mixed model. 
*p  .05. **p  .01. ***p  .001 (two-tailed). 
Table 3. Self-Reported Hereditary Aspects of ADHD + SUD and SUD  ADHD Patients (N = 94). 
Patient characteristics 
All SUD patients SUD + ADHD group SUD  ADHD group 
% n % n % n 
ADHD diagnosis in consanguineous relatives  94  16  78 
 No 76.6 72 43.8 7 83.3 65 
 First-degree relative(s) 7.4 7 18.8 3 5.1 4 
 Second-degree relative(s) 5.3 5 18.8 3 2.6 2 
 Both first and second-degree relativesa 4.3 4 12.5 2 2.6 2 
 Not sure 6.4 6 6.2 1 6.4 5 
Substance use and/or psychiatric problems in consanguineous relatives  94  16  78 
 No 27.7 26 6.2 1 32.1 25 
 Substance use in first-degree relative(s) 24.5 23 43.8 7 20.5 16 
 Substance use in second-degree relative(s) 5.3 5 0 0 6.4 5 
 Substance use in both first and second-degree relativesa 7.4 7 12.5 2 6.4 5 
 Other psychiatric problemsb 13.8 13 18.8 3 12.8 10 
 Both substance use and other psychiatric problems 14.9 14 12.5 2 15.4 12 
 Not sure 6.4 6 6.2 1 6.4 5 
Note. SUD = substance use disorders. 
aDifferent relatives of those counted into the two previous categories. 
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bMost frequently reported mood and anxiety problems. Including first- and second-degree relatives. 
 
Personality 
As shown in Table 2, in unadjusted results, SUD + ADHD 
patients reported significantly (p < .01) higher ambition 
(persistence subdimension) and self-forgetfulness (self-
transcendence subdimension) than SUD  ADHD patients, 
who reported significantly higher fear of uncertainty (harm 
avoidance subdimension). SUD + ADHD patients tended 
(p < .05) to report elevated impulsiveness (novelty seeking 
subdimension) and eagerness to effort (persistence 
subdimension) compared with SUD  ADHD patients. 
Furthermore, SUD  ADHD patients tended to report 
higher fatigability (harm avoidance subdimension) and 
dependence (reward dependence subdimension) scores, 
compared with SUD + ADHD patients. When adjusted for 
age, eagerness to effort among SUD + ADHD patients 
compared with SUD  ADHD patients, became 
significant. The significantly higher fear of uncertainty 
among SUD  ADHD patients compared with SUD + 
ADHD patients, remained. In addition, SUD + ADHD 
patients tended to report higher scores on ambition and 
self-forgetfulness, compared with SUD  ADHD patients. 
The effect size for fear of uncertainty was large, whereas 
the effect sizes for the significant differences and 
tendencies were medium. 
Readiness to Change 
A significantly lower recognition of problematic substance 
use in SUD + ADHD patients compared with SUD  
ADHD patients was found. However, after adjusting for 
age, this difference became a tendency with a medium 
effect, as seen in Table 2. As individuals under opioid 
maintenance therapy might not consider their opiate 
addiction as problematic, we controlled for this variable 
both in the original and the adjusted analyses, and the 
results were almost identical (data not shown). 
Discussion 
The aim of this study was to explore possible differences 
in personality and readiness to change between SUD + 
ADHD patients and SUD  ADHD patients. With regard 
to personality, SUD + ADHD patients were characterized 
by lowered harm avoidance, specifically, they reported 
significantly lower scores on the subdimension fear of 
uncertainty. They were also characterized by elevated 
persistence, reporting significantly higher eagerness to 
effort scores and tending to report elevated ambition. 
Although no significant differences were found between 
groups in self-transcendence, SUD + ADHD patients 
tended to report elevated self-forgetfulness, a 
subdimension of self-transcendence, compared with SUD 
 ADHD patients. There were no differences between 
groups on high novelty seeking, low self-directedness, and 
cooperativeness. As for readiness to change, no significant 
differences were found between groups. However, SUD + 
ADHD patients tended to report lower recognition to 
change problematic substance use compared with SUD  
ADHD patients. 
Cloninger et al. (1994) proposed that people with 
lowered harm avoidance and fear of uncertainty are 
energetic, daring and less careful even in situations in 
which one is expected to be cautious. Likely related to the 
executive deficits in ADHD, SUD + ADHD patients make 
less thorough decisions in situations concerning substance 
use, which can impact them negatively. Furthermore, the 
elevated eagerness to effort among SUD + ADHD patients 
indicates zeal to initiate tasks in response to anticipated 
reward (Cloninger et al., 1994). Interestingly, SUD + 
ADHD patients did not report elevated scores on the other 
persistence subdimensions of perfectionism and work hard 
(Supplementary Table 1). Salgado et al. (2009) found high 
persistence related to the hyperactive and impulsive 
domains of ADHD. The elevated eagerness to effort 
among SUD + ADHD patients compared with SUD  
ADHD patients might additionally be related to the 
emotional intensity, characteristic of ADHD (Kooij et al., 
2010). SUD + ADHD patients low in fear of uncertainty 
and high eagerness to effort might be flexible to try 
different treatment strategies. On the other hand, SUD + 
ADHD patients might incur in high risk situations, give up 
tasks easily, hence sticking to the treatment plan less 
meaningfully. 
The tendencies among SUD + ADHD patients of 
lowered recognition of having a problematic substance 
use, in addition to being ambitious and self-forgetful, can 
be related to the attentional problems, reward-processing 
and self-monitoring deficits in ADHD (Asherson et al., 
2016). A prerequisite for intentional change to take place 
is recognizing the problematic behavior (Prochaska et al., 
1992). In SUD + ADHD patients, the attention problems 
possibly interfere with making thorough reflections 
regarding own substance use. 
For instance, Tamm, Adinoff, Nakonezny, Winhusen, 
and Riggs (2012) found that the inattentive presentation of 
ADHD among comorbid SUD adolescents was associated 
with a lowered readiness to change. Moreover, the 
elevated self-forgetfulness among SUD + ADHD patients 
might be related to their lowered recognition of having 
problematic substance use. Self-forgetfulness refers to 
losing the notion of time and space, being creative and 
immerse in the moment (Cloninger et al., 1994). Such a 
definition of self-forgetfulness resembles the unintentional 
mind-wandering in ADHD (Mostert et al., 2016), which 
can be maladaptive because it is involuntary. The 
hyperactive and impulsive aspects of ADHD might be 
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related to the elevated ambition among SUD + ADHD 
patients. These can be expressed as frequent emerging 
plans or ideas that get initiated but remain unfinished 
(Kooij et al., 2010). 
The high novelty seeking (i.e., acting before thinking, 
quick temper, mood swings, impulsivity) found in both 
SUD patient groups is in line with earlier research (e.g., 
Evren et al., 2007; Sizoo et al., 2009) but contrary to our 
expectations. The deficits in the reward system in SUD 
(Volkow & Baler, 2014), where the goal-directed behavior 
becomes biased toward substance-related activities, may 
explain these findings. The low self-directedness and 
cooperativeness scores we found in both SUD groups have 
consistently been linked to psychopathology (e.g., 
Josefsson et al., 2011; Pedrero Perez et al., 2011). Elevated 
self-directedness and cooperativeness reflect a self-
regulated purposeful, responsible, empathetic and tolerant 
character (Cloninger et al., 1994). Notably, elevated self-
directedness and cooperativeness are associated with 
maturity and well-being, independently of temperament 
styles (Cloninger, 2004; Cloninger & Zohar, 2011). Thus, 
increased self-awareness about own resources and 
challenges might facilitate purposefulness and maturity. 
Clinical Characteristics 
No significant differences were found between groups in 
terms of clinical characteristics. However, SUD + ADHD 
patients tended to be younger and had more frequently 
amphetamine addiction than SUD  ADHD patients. SUD 
 ADHD patients tended to be more often diagnosed with 
alcohol SUD. These tendencies were in line with the 
literature (Evren et al., 2007; Johann et al., 2003; van 
Emmerik-van Oortmerssen et al., 2014). Contrary to 
previous findings consistently suggesting a higher 
psychiatric comorbidity among SUD and ADHD patients 
(van Emmerik-van Oortmerssen et al., 2014; Wilens et al., 
2005), a high frequency of Axis I (current) and Axis II 
psychiatric comorbidities (particularly anxiety, depression, 
borderline, schizoid and antisocial personality disorders) 
was found among SUD  ADHD patients only. 
In line with other studies, we found a prevalence of 
adult ADHD among SUD patients of 15.5%, the vast 
majority (91%) were assessed as adults (Halmoy, Fasmer, 
Gillberg, & Haavik, 2009; van de Glind et al., 2014). 
Possibly, the havoc caused by SUD comorbidity might 
have delayed the ADHD assessment in these individuals, 
as discussed by Løvaas and Dahl (2013). 
Strengths and Limitations 
One of the strengths of this naturalistic exploratory study 
is that SUD patients with an ADHD diagnosis were 
naturally encountered during the recruitment process in 
SUD treatment. Assessment and clinical diagnosis of 
ADHD were in accordance with the Norwegian diagnostic 
guidelines for ADHD. The majority of instruments used 
had an acceptable to excellent reliability. By addressing 
personality and readiness to change in the field of SUD 
and ADHD, this study contributes with additional 
knowledge of an otherwise little explored area. There are 
some limitations in this study: (a) the relatively small 
sample sizes which limit representativity and the 
underrepresentation of women in the SUD + ADHD 
group; (b) findings based on p < .05 increase the risk of 
false positive inferences; (c) the impact of 
psychopharmacological treatment, crucial to improve 
ADHD symptomatology in SUD + ADHD patients was 
out of the scope of this study; (d) the multiple SOCRATES 
scales per patient can have compromised our findings on 
readiness to change; (e) our findings may be biased 
because they might represent SUD + ADHD patients with 
a better mental health than those commonly presented in 
the literature; (f) only current substance dependence 
diagnostic criteria were applied. Similarly, only current 
(no lifetime) Axis I diagnoses were considered when full 
symptom criteria were met. (g) Finally, this study was 
conducted before the Diagnostic and Statistical Manual of 
Mental Disorders (5th ed.; DSM-5; APA, 2013) was 
introduced. Possibly, DSM-5 diagnostic criteria could have 
resulted in a different prevalence of psychopathology. 
Clinical Implications 
This study indicates that SUD + ADHD patients benefit 
from understanding how or whether their substance use is 
related to their personality styles. Moreover, by openly 
discussing readiness to change, SUD + ADHD patients 
may be in a better position to make intentional changes in 
relation to their substance use problems. However, due to 
the executive dysfunctions in ADHD, such discussion 
might be more demanding for both patients and clinicians. 
SUD + ADHD patients may further benefit from breaking 
down their treatment goals into smaller and realistic goals, 
incorporating frequent rewards to SUD treatment and 
focusing on the prevention of high risk situations for 
substance use. By encouraging self-awareness and the 
active involvement in SUD treatment, these patients might 
grow in self-directedness and cooperativeness, maturity, 
and well-being. 
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